• Teduglutide

    Teduglutide is a peptide made up of 33 amino acids. It differs from GLP-2 by one amino acid (A to G), which makes it more resistant to dipeptidyl peptidase-4 proteolysis, giving it a longer half-life as compared to endogenous GLP-2. FDA approved on December 21, 2012.

    Published On: December 15th, 2023Categories: Generic Peptide APIs
  • 25 years developing GLP-1 mimetics for diabetes and metabolic diseases – the future is still very bright.

    This presentation will focus on the development of the latest GLP-1 mimetics and GLP-1/GIP dual agonists, with unparalleled efficacy and ease of delivery.

    Published On: November 19th, 2023Categories: Webinars
  • Cetrorelix DMF Submission Announcement

    SAN JOSE, CA., June 25, 2020 /CPCNewswire/ — CPC Scientific Inc., a San Jose based CDMO with GMP manufacturing facilities in Hangzhou, is pleased to announce that their drug master file (DMF) for cetrorelix acetate has been submitted to the U.S. Food and Drug Administration and has been issued DMF# 034884. This generic peptide API […]

    We are very excited about the addition of the cetrorelix DMF to our growing generic peptide portfolio. Our multi-kg scale cGMP manufacturing facility for cetrorelix will provide more opportunities for IVF treatments in the medical communities and pathways to new treatments for hormone-sensitive breast and prostate cancers.

    Published On: June 25th, 2020Categories: GMP Peptide Manufacturing, Press Releases